|
End-of-day quote
Shanghai S.E.
12/08/2026
|
5-day change | 1st Jan Change | ||
| 18.14 CNY | -3.82% |
|
-0.66% | +2.95% |
| 24/04 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 24/04 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
| 25/08/2026 | Earnings release - Q2 2026 |
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
| 18/05/2026 | Annual General Meeting | 11:00 am |
| 18/05/2026 | Earnings presentation | 06:00 pm |
| 24/04/2026 | Earnings release - Annual 2025 | |
| 24/04/2026 | Earnings release - Q1 2026 | |
| 30/03/2026 | Extraordinary General Meeting | 01:00 pm |
| 09/12/2025 | Earnings presentation | 07:00 pm |
| 21/11/2025 | Extraordinary General Meeting | 01:00 pm |
| 30/10/2025 | Earnings release - Q3 2025 | |
| 26/09/2025 | Earnings presentation | 06:00 pm |
| 15/09/2025 | Extraordinary General Meeting | 12:30 pm |
| 29/08/2025 | Earnings release - Q2 2025 |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
| 26/06/2026 | Ex-dividend date - 0.49 CNY | 02:00 pm |
| 06/11/2025 | Ex-dividend date - 0.34 CNY | 04:00 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 24 531 24 720 -0.76% | 26 497 26 779 -1.05% | 27 502 27 576 -0.27% | 29 906 | 33 032 | 36 680 |
|
EBITDA Million CNY | Released Forecast Spread | 2 119 2 532 -16.31% | 3 395 3 349 1.4% | 3 833 3 281 16.84% | 3 761 | 4 251 | 4 791 |
|
EBIT Million CNY | Released Forecast Spread | 1 632 1 868 -12.66% | 1 501 1 673 -10.32% | 2 038 1 881 8.36% | 2 278 | 2 621 | 2 993 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 628 1 807 -9.91% | 1 340 1 496 -10.42% | 1 849 1 702 8.66% | 2 195 | 2 534 | 2 897 |
|
Net income Million CNY | Released Forecast Spread | 1 166 1 303 -10.51% | 915 1 152 -20.57% | 1 235 1 186 4.15% | 1 485 | 1 714 | 1 954 |
|
EPS CNY | Released Forecast Spread | 1,03 1,15 -10.59% | 0,81 1,05 -23.07% | 1,08 1,04 4.26% | 1,30 | 1,50 | 1,72 |
| Announcement Date | 28/04/24 | 25/04/25 | 23/04/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 6 386 6 364 0.34% | 6 766 7 282 -7.09% | 6 956 7 159 -2.84% | 6 567 7 200 -8.79% | 6 546 6 554 -0.12% | 7 434 7 262 2.37% | 6 973 7 184 -2.93% | 7 281 | 7 472 | 8 185 | 7 854 | 8 019 | 8 019 | 8 500 | 8 274 |
|
EBITDA Million CNY | Released Forecast Spread | 851 | 613 | 827 | 882 | 791 | 682 | 1 066 | 996 | 943 | 781 | 1 103 | 1 262 | 1 214 | 738 | 1 054 |
|
EBIT Million CNY | Released Forecast Spread | 295 422 -30.2% | 230 | 650 | 476 403 18% | 410 330 24.26% | 502 226 122.08% | 710 692 2.64% | 568 | 566 | 409 | 650 | 857 | 809 | 333 | 633 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 278 384 -27.52% | 160 146 10% | 649 362 79.29% | 474 404 17.44% | 398 314 26.73% | 327 215 52.58% | 707 670 5.55% | 598 | 545 | 374 | 668 | 826 | 778 | 300 | 600 |
|
Net income Million CNY | Released Forecast Spread | 201 275 -27.16% | 56,6 75,8 -25.28% | 460 255 80.19% | 338 276 22.59% | 283 192 47% | 154 130 18.36% | 511 521 -1.87% | 423 | 370 | 205 | 474 | 619 | 571 | 81,0 | 378 |
|
EPS CNY | Released Forecast Spread | 0,18 0,24 -24.13% | 0,06 0,11 -44.88% | 0,40 0,31 29.85% | 0,30 0,24 22.92% | 0,25 0,18 39.3% | 0,13 0,08 59.55% | 0,45 0,44 3.26% | 0,34 | 0,32 | 0,17 | 0,38 | 0,43 | 0,40 | 0,30 | 0,33 |
| Announcement Date | 30/10/24 | 25/04/25 | 25/04/25 | 28/08/25 | 29/10/25 | 23/04/26 | 23/04/26 | - | - | - | - | - | - | - | - |
| 16/08/2026 |  | Ex-dividend date - 2.6 SAR | 02:00 pm |
| 17/08/2026 | | Annual General Meeting | 08:00 pm |
| 17/08/2026 | | Présentation aux Actionnaires / Analystes | 08:00 pm |
| 19/08/2026 | | Earnings release - Q2 2026 | |
| 19/08/2026 | | Earnings presentation | |
| 20/08/2026 | | Sales and Revenue Release - Annual 2026 | |
| 26/08/2026 | | Extraordinary General Meeting | 04:00 pm |
| 26/08/2026 | | Earnings release - Q2 2026 | |
| 27/08/2026 | | Earnings release - Q2 2026 | |
| 28/08/2026 | | Earnings release - Q2 2026 |
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
| Today | | Board of Directors Meeting | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings presentation | 07:00 pm |
| 12/08/2026 | | Ex-dividend date for special dividend - 0.1562 HKD | 02:00 pm |
| 12/08/2026 | | Ex-dividend date for special dividend - 0.0687 HKD | 02:00 pm |
| 10/08/2026 | | Earnings release - Q1 2027 | P |
| 07/08/2026 | | Annual General Meeting | 01:00 pm |
| 07/08/2026 | | Earnings release - Q2 2026 | |
| 07/08/2026 | | Earnings presentation | 06:30 am |
| 31/07/2026 | | Annual General Meeting |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
